Evidence map›Paper›PMID 36614300›Full record

ArticleInternational journal of molecular sciences2023

E96V Mutation in the

Delsi Altenhofen, Jenny Minh-An Khuong, Tanja Kuhn, Sandra Lebek, Sarah Görigk, Katharina Kaiser, Christian Binsch, Kerstin Griess, Birgit Knebel, Bengt-Frederik Belgardt and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Delsi AltenhofenInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Jenny Minh-An KhuongInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Tanja KuhnInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Sandra LebekInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Sarah GörigkInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Katharina KaiserInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Christian BinschInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Kerstin GriessGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, 85764 Oberschleißheim, Germany.ORCID 0000-0002-6672-2394
Birgit KnebelInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-5575-4315
Bengt-Frederik BelgardtGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, 85764 Oberschleißheim, Germany.
Sandra CamesInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0003-1021-1613
Samaneh EickelschulteInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-8040-8393
Torben StermannInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Axel RascheMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Ralf HerwigMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Jürgen WeissInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Heike VogelGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, 85764 Oberschleißheim, Germany.
Annette SchürmannGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, 85764 Oberschleißheim, Germany.ORCID 0000-0002-4113-4377
Alexandra ChadtInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0003-3873-1477
Hadi Al-HasaniInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Deutsches Diabetes-Zentrum e.V. · DEMax Planck Institute for Molecular Genetics · DEUniversity of Potsdam · DE

Funding

German Center for Diabetes Research 82DZD00302
6 · The paper itself

Abstract

Type 2 diabetes (T2D) represents a multifactorial metabolic disease with a strong genetic predisposition. Despite elaborate efforts in identifying the genetic variants determining individual susceptibility towards T2D, the majority of genetic factors driving disease development remain poorly understood. With the aim to identify novel T2D risk genes we previously generated an N2 outcross population using the two inbred mouse strains New Zealand obese (NZO) and C3HeB/FeJ (C3H). A linkage study performed in this population led to the identification of the novel T2D-associated quantitative trait locus (QTL)

Indexed as

Diabetes Mellitus, Type 2Genetic Predisposition to DiseaseObesityReceptors, PeptideAnimalsInsulinInsulin-Secreting CellsMiceMice, Inbred C3HMice, ObeseInsulinKDEL receptorReceptors, Peptideendoplasmic reticulum stressinsulin secretionpancreatic islet functionpositional cloningtype 2 diabetes susceptibility

Identifiers

PMID36614300
PMCPMC9820861
OpenAlexW4313583522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.